In contrast, the Kras mutation is not always present in the colon tumors of AOM/DSS-treated mice [30], consistent with the fact that Kras mutation less frequently occurs in colitis-associated colorectal tumors than sporadic tumors [31]. This evidence concerns the gene KRAS and colonic neoplasm.